16-66923524-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2

The NM_004165.3(RRAD):​c.641C>T​(p.Ser214Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,605,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

RRAD
NM_004165.3 missense

Scores

8
10
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.00
Variant links:
Genes affected
RRAD (HGNC:10446): (RRAD, Ras related glycolysis inhibitor and calcium channel regulator) Predicted to enable GTP binding activity and calcium channel regulator activity. Predicted to be involved in small GTPase mediated signal transduction. Predicted to be located in cytosol. Predicted to be active in plasma membrane. Implicated in type 2 diabetes mellitus. Biomarker of congestive heart failure. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.882
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RRADNM_004165.3 linkc.641C>T p.Ser214Leu missense_variant Exon 4 of 5 ENST00000299759.11 NP_004156.1 P55042A0A024R6X0
RRADNM_001128850.2 linkc.641C>T p.Ser214Leu missense_variant Exon 4 of 5 NP_001122322.1 P55042A0A024R6X0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RRADENST00000299759.11 linkc.641C>T p.Ser214Leu missense_variant Exon 4 of 5 1 NM_004165.3 ENSP00000299759.6 P55042
RRADENST00000566577.1 linkc.324+89C>T intron_variant Intron 3 of 3 5 ENSP00000462559.1 J3KSM6
RRADENST00000568915.5 linkc.237+322C>T intron_variant Intron 2 of 2 5 ENSP00000461995.1 J3KRG9
RRADENST00000567791.1 linkn.375C>T non_coding_transcript_exon_variant Exon 1 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.0000464
AC:
7
AN:
150814
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000733
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000290
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000296
Gnomad OTH
AF:
0.000485
GnomAD3 exomes
AF:
0.0000203
AC:
5
AN:
246310
Hom.:
0
AF XY:
0.0000300
AC XY:
4
AN XY:
133540
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000178
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000124
AC:
18
AN:
1454266
Hom.:
0
Cov.:
32
AF XY:
0.0000180
AC XY:
13
AN XY:
723606
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000213
Gnomad4 NFE exome
AF:
0.00000720
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000464
AC:
7
AN:
150814
Hom.:
0
Cov.:
32
AF XY:
0.0000679
AC XY:
5
AN XY:
73674
show subpopulations
Gnomad4 AFR
AF:
0.0000733
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.000290
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000296
Gnomad4 OTH
AF:
0.000485
Bravo
AF:
0.0000416
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 22, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.641C>T (p.S214L) alteration is located in exon 4 (coding exon 3) of the RRAD gene. This alteration results from a C to T substitution at nucleotide position 641, causing the serine (S) at amino acid position 214 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Uncertain
0.034
T
BayesDel_noAF
Uncertain
0.050
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.81
D;D
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.93
D;.
M_CAP
Uncertain
0.22
D
MetaRNN
Pathogenic
0.88
D;D
MetaSVM
Uncertain
0.63
D
MutationAssessor
Uncertain
2.9
M;M
PrimateAI
Pathogenic
0.82
D
PROVEAN
Pathogenic
-5.3
D;D
REVEL
Pathogenic
0.78
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.0030
D;D
Polyphen
1.0
D;D
Vest4
0.85
MutPred
0.58
Loss of disorder (P = 0.0107);Loss of disorder (P = 0.0107);
MVP
0.95
MPC
1.4
ClinPred
0.97
D
GERP RS
4.8
Varity_R
0.82
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs747510316; hg19: chr16-66957427; API